T-cell Redirecting Therapies for the Treatment of B-cell Lymphomas: Recent Advances

SIMPLE SUMMARY: B-cell non-Hodgkin lymphomas (NHL) include many diseases with distincts pathogenic mechanisms, prognoses and management. Most patients benefit generally from efficient therapies allowing cure or prolonged remission. However, when they are refractory or relapse after standard therapy,...

Descripción completa

Detalles Bibliográficos
Autores principales: Messéant, Ondine, Houot, Roch, Manson, Guillaume
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428367/
https://www.ncbi.nlm.nih.gov/pubmed/34503084
http://dx.doi.org/10.3390/cancers13174274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428367/
https://www.ncbi.nlm.nih.gov/pubmed/34503084
http://dx.doi.org/10.3390/cancers13174274

Ejemplares similares